Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125687361 | 12568736 | 1 | I | 20160712 | 20160719 | 20160719 | EXP | CA-AMGEN-CANSP2016091071 | AMGEN | 0.00 | F | Y | 0.00000 | 20160719 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125687361 | 12568736 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, UNK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | ||||||
| 125687361 | 12568736 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | 640 MG, QWK | 0 | 640 | MG | /wk | |||||||
| 125687361 | 12568736 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 125687361 | 12568736 | 4 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | 200 MG, QWK | 0 | 200 | MG | /wk | |||||||
| 125687361 | 12568736 | 5 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | Unknown | UNK | 0 | CAPSULE | |||||||||
| 125687361 | 12568736 | 6 | SS | GOLD | GOLD | 1 | Unknown | UNK | 0 | ||||||||||
| 125687361 | 12568736 | 7 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | 40 MG, QWK | 0 | 40 | MG | /wk | |||||||
| 125687361 | 12568736 | 8 | SS | IMURAN | AZATHIOPRINE | 1 | Unknown | UNK | 0 | ||||||||||
| 125687361 | 12568736 | 9 | SS | INFLIXIMAB | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | 300 MG, QWK | 0 | 300 | MG | /wk | |||||||
| 125687361 | 12568736 | 10 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 | ||||||||||
| 125687361 | 12568736 | 11 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 125687361 | 12568736 | 12 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125687361 | 12568736 | 1 | Rheumatoid arthritis |
| 125687361 | 12568736 | 2 | Product used for unknown indication |
| 125687361 | 12568736 | 3 | Rheumatoid arthritis |
| 125687361 | 12568736 | 4 | Rheumatoid arthritis |
| 125687361 | 12568736 | 5 | Rheumatoid arthritis |
| 125687361 | 12568736 | 6 | Rheumatoid arthritis |
| 125687361 | 12568736 | 7 | Rheumatoid arthritis |
| 125687361 | 12568736 | 8 | Rheumatoid arthritis |
| 125687361 | 12568736 | 9 | Rheumatoid arthritis |
| 125687361 | 12568736 | 10 | Rheumatoid arthritis |
| 125687361 | 12568736 | 11 | Rheumatoid arthritis |
| 125687361 | 12568736 | 12 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125687361 | 12568736 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125687361 | 12568736 | Blood iron abnormal | |
| 125687361 | 12568736 | Drug ineffective | |
| 125687361 | 12568736 | Drug intolerance | |
| 125687361 | 12568736 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |